Real-world benefits of selected innovative drug classes in Switzerland
Research Project | 01.09.2026 - 31.12.2027
|
01.09.2026
- 31.12.2027
Funding
Real-world benefits of selected innovative drug classes in Switzerland
Industriegelder, Sonstige Forschungskooperationen (GrantsTool), 09.2026-12.2027 (16)
PI : Schwenkglenks, Matthias.CI : Antillon, Marina.
Members (2)
Matthias Schwenkglenks
Principal Investigator
